View Post

Dr. Gradishar on Pretreatment With Cetirizine to Prevent Infusion Reactions in Breast Cancer and Other Malignancies

In Clinical Studies News by Barbara Jacoby

By: William J. Gradishar, MD   From: onclive.com William Gradishar, MD, discusses the efficacy of pretreatment with intravenous cetirizine in the prevention of infusion reactions in patients with breast cancer and other malignancies. William Gradishar, MD, the chief of hematology and oncology, Department of Medicine, Betsy Bramsen Professorship of Breast Oncology, and a professor of medicine (hematology and oncology) at …

View Post

FDA Approves Neratinib Combo for HER2+ Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Gina Columbus From: onclive.com The FDA has approved a supplemental new drug application (sNDA) for neratinib (Nerlynx) in combination with capecitabine (Xeloda) for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received ≥2 prior anti–HER2-based regimens in the metastatic setting.1 The approval is based on findings from the phase III NALA trial, which …

View Post

Breast Cancer Vaccine Trial May Blaze Trail to Stopping Cancer

In In The News by Barbara Jacoby

From: healthline.com A trial is underway for a breast cancer vaccine. Scientists are hoping this latest immunotherapy will help keep patients from developing cancer again. Researchers are hoping that they’ll soon break ground in a new medical frontier. Vaccines that can stop cancer. Currently, the only vaccine designed to prevent cancer is the HPV vaccine. However, that shot protects against …

View Post

Cancer treatment trials using patient’s own cells to destroy solid tumours ‘will begin within a year’

In In The News by Barbara Jacoby

By: Steve Connor, Science Editor From: independent.co.uk The trial may bring the most major advance in cancer treatment since chemotherapy The first large-scale clinical trial of a new kind of cancer treatment using a patient’s own natural “killer cells” to destroy solid tumours will begin within a year, scientists have told The Independent on Sunday. Dozens of patients with advanced …

View Post

Doctors hope new breast cancer vaccine will save lives

In In The News by Barbara Jacoby

By: Brittany Jones From: actionnewsjax.com Part of a nearly $13.3 million Department of Defense grant will be used in our area to develop a vaccine for breast cancer. Currently, 280 patients are participating in the trial. Dr. Keith Knutson has been working with breast cancer patients for about ten years. “In addition to me being touched, the burden breast cancer …

UPDATED: Kite Pharma spikes on its second take of CAR-T cancer study

In In The News by Barbara Jacoby

By: John Carroll From: fiercebiotech.com Kite Pharma has once again demonstrated just how hot experimental CAR-T technology is in the cancer field. The Santa Monica, CA-based biotech reported Monday evening in a trial update that 12 of 13 evaluable patients with advanced B cell malignancies demonstrated a complete or partial response after being treated with its chimeric antigen receptor (CAR) …